Unisphere Establishment’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.01B Buy
2,060,000
+100,000
+5% +$54.3M 8.52% 2
2025
Q4
$1.14B Sell
1,960,000
-100,000
-5% -$56.6M 8.49% 2
2025
Q3
$999M Hold
2,060,000
7.83% 3
2025
Q2
$835M Buy
2,060,000
+110,000
+6% +$46M 6.73% 7
2025
Q1
$970M Buy
1,950,000
+250,000
+15% +$135M 8.47% 2
2024
Q4
$884M Buy
1,700,000
+100,000
+6% +$55M 7.71% 3
2024
Q3
$990M Buy
1,600,000
+100,000
+7% +$59.2M 9.38% 2
2024
Q2
$830M Buy
1,500,000
+100,000
+7% +$57.3M 8.35% 2
2024
Q1
$814M Buy
1,400,000
+50,000
+4% +$28.1M 8.22% 2
2023
Q4
$717M Buy
+1,350,000
New +$653M 7.41% 4

Other funds holding TMO

Unisphere Establishment's TMO Position: Q1 2026 in Review

Unisphere Establishment increased its Thermo Fisher Scientific (TMO) stake by 5.1% in Q1 2026, buying an estimated $54.3M and bringing the position to 2,060,000 shares worth $1.01B. The position accounts for 8.52% of the portfolio, ranked #2.

Unisphere Establishment first reported a position in TMO in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.14B in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Unisphere Establishment held 2,060,000 shares of Thermo Fisher Scientific worth $1.01B as of Q1 2026.
  • Unisphere Establishment bought 100,000 Thermo Fisher Scientific shares in Q1 2026, an estimated $54.3M.
  • Thermo Fisher Scientific made up 8.52% of Unisphere Establishment's portfolio in Q1 2026, its #2 holding.
  • Unisphere Establishment first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 10 quarters since.
  • Unisphere Establishment's Thermo Fisher Scientific position peaked at $1.14B in Q4 2025.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Unisphere Establishment's 13F filing for Q1 2026, filed 14 May 2026.